a 802715 has been researched along with pentoxifylline in 6 studies
| Studies (a 802715) | Trials (a 802715) | Recent Studies (post-2010) (a 802715) | Studies (pentoxifylline) | Trials (pentoxifylline) | Recent Studies (post-2010) (pentoxifylline) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 4,437 | 657 | 943 |
| Protein | Taxonomy | a 802715 (IC50) | pentoxifylline (IC50) |
|---|---|---|---|
| Acetylcholinesterase | Homo sapiens (human) | 6.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alléra, A; Eisenhut, T; Endres, S; Gebert, U; Moeller, J; Schönharting, MM; Semmler, J | 1 |
| Birg, A; Frank, G; Hoffmann, H; Jochum, M; Schönharting, MM; Weis, M | 1 |
| Lin, Y; Mikhalsky, D; Schönharting, M; Segers, C; Tjandra-Maga, TB; Waer, M | 1 |
| Ceuppens, J; Goebels, J; Kasran, A; Lin, Y; Rutgeerts, O; Schönharting, M; Van Gool, S; Waer, M | 1 |
| Bitter-Suermann, S; Burdon, D; Entzian, P; Ernst, M; Schlaak, M; Zabel, P | 1 |
| Binder, A; Bohm, L; Theron, T | 1 |
6 other study(ies) available for a 802715 and pentoxifylline
| Article | Year |
|---|---|
Xanthine derivatives: comparison between suppression of tumour necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Pentoxifylline; Theophylline; Tumor Necrosis Factor-alpha; Xanthines | 1993 |
Amelioration of endotoxin-induced acute lung injury in pigs by HWA 138 and A 80 2715: new analogs of pentoxifylline.
Topics: Animals; Bronchodilator Agents; Hemodynamics; Infusions, Intravenous; Leukocyte Count; Leukopenia; Lipopolysaccharides; Pentoxifylline; Pulmonary Circulation; Respiratory Distress Syndrome; Shock, Septic; Swine; Swine, Miniature; Xanthines | 1995 |
Use of the methylxanthine derivative A802715 in transplantation immunology: II. In vivo experiments.
Topics: Administration, Oral; Animals; Cyclosporine; Drug Synergism; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Infusions, Intravenous; Lymphocyte Activation; Male; Pentoxifylline; Rats; Rats, Inbred Strains; Xanthines | 1997 |
Use of the methylxanthine derivative A802715 in transplantation immunology: I. Strong in vitro inhibitory effects on CD28-costimulated T cell activities.
Topics: Animals; Antibodies, Monoclonal; CD28 Antigens; CD3 Complex; Cyclosporine; Dose-Response Relationship, Drug; Drug Synergism; Humans; Immunosuppression Therapy; Interferon-gamma; Interleukin-10; Interleukin-6; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Mice; Pentoxifylline; Receptors, Interleukin-2; T-Lymphocytes; Transplantation Immunology; Tumor Necrosis Factor-alpha; Xanthines | 1997 |
Differences in the anti-inflammatory effects of theophylline and pentoxifylline: important for the development of asthma therapy?
Topics: Adult; Aged; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Blood Cells; Cells, Cultured; Female; Humans; Interferon-gamma; Interleukin-6; Lipopolysaccharides; Male; Middle Aged; Pentoxifylline; Phytohemagglutinins; Reactive Oxygen Species; Theophylline; Tumor Necrosis Factor-alpha; Xanthines | 1998 |
Influence of pentoxifylline, A-802710, propentofylline and A-802715 (Hoechst) on the expression of cell cycle blocks and S-phase content after irradiation damage.
Topics: Caffeine; Cell Cycle; Dose-Response Relationship, Drug; Enzyme Inhibitors; G2 Phase; Gentian Violet; Growth Inhibitors; Humans; Indicators and Reagents; Mitosis; Molecular Structure; Nocodazole; Pentoxifylline; Radiation-Sensitizing Agents; S Phase; Time Factors; Tumor Cells, Cultured; Xanthines | 2000 |